osimertinib
astrazeneca
['nsclc', 'lcsm,(-blcsm)', 'sclc', 'osimertinib']
fantastic discussion from prof at the #asco23 plenary! adjuvant osimertinib in pts w egfrm nsclc #lcsm 
GI med onc @PeterMacCC, Director @ACSC_PeterMac, Professor @UniMelb. Board @COSAoncology, #survonc, other roles w @ASCO & @IPOSPsychoOncol. Own views 🇦🇺🏳️‍🌈